Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity Study in VLBW Neonates of BSYX-A110 (N003)

This study has been completed.
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by:
Biosynexus Incorporated
ClinicalTrials.gov Identifier:
NCT00631800
First received: February 29, 2008
Last updated: NA
Last verified: February 2008
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2004
  Primary Completion Date: March 2004 (Final data collection date for primary outcome measure)
No publications provided by Biosynexus Incorporated

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):